Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.30 USD
Change Today +0.18 / 8.49%
Volume 2.8M
As of 8:10 PM 06/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Scott Daniel Cormack

Founder, Chief Executive Officer, President, Treasurer, Secretary and Director, OncoGenex Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Scott Daniel Cormack has been the Chief Executive Officer and President of OncoGenex Pharmaceuticals, Inc. since August 2008 and served as its Chief Financial Officer. Mr. Cormack founded OncoGenex Pharmaceuticals Inc. in 2000. He has been Treasurer of OncoGenex Pharmaceuticals Inc. since January 31, 2013. He served as the Secretary of OncoGenex Pharmaceuticals Inc. since February 2010 and its Principal Financial Officer since January 31, 2013. He has over 10 years ...

Read Full Background

Corporate Headquarters*

19820 North Creek Parkway
Bothell, Washington 98021

United States

Phone: 425-686-1500
Fax: --

Board Members Memberships*

Former Director
Founder, Chief Executive Officer, President, Treasurer, Secretary and Director


University of Alberta

Other Affiliations*

Annual Compensation*

Total Annual Compensation$497,153

Stock Options*

Restricted Stock Awards$655,320
Exercisable Options221,764
Unexercisable Options68,236
Total Number of Options290,000

Total Compensation*

Total Annual Cash Compensation$653,477
Total Short Term Compensation$497,153
Other Long Term Compensation$655,320
Total Calculated Compensation$1,719,118
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OGXI:US $2.30 USD +0.18


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOGENEX PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at